Evidence map›Paper›PMID 19563893›Full record

ArticleThe Journal of steroid biochemistry and molecular biology2009

Progestin stimulation of manganese superoxide dismutase and invasive properties in T47D human breast cancer cells.

Aaron K Holley, Kelley K Kiningham, Douglas R Spitz, Dean P Edwards, Jeffrey T Jenkins, Michael R Moore

Open access · greenAbstract read
In one paragraph

Article in The Journal of steroid biochemistry and molecular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Molecules (Basel, Switzerland) · 2022
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Manganese superoxide dismutase: guardian of the powerhouse.International journal of molecular sciences · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Aaron K HolleyDepartment of Biochemistry & Microbiology, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755-9320, USA.
Kelley K Kiningham
Douglas R Spitz
Dean P Edwards
Jeffrey T Jenkins
Michael R Moore
Marshall University · USBaylor College of Medicine · USBelmont University · USUniversity of Iowa · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
WVU &MU NEW FACULTY GRANTSP20RR016477 · NCRR · MARSHALL UNIVERSITY · PI RANKIN, GARY O · 2001 to 2011
$35.5M
Transcription Factors in CancerP20RR020180 · NCRR · MARSHALL UNIVERSITY · PI NILES, RICHARD M. · 2004 to 2009
$9.5M
STEROID ANTAGONISTS AND RESISTANCE IN BREAST CANCERR01DK049030 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI EDWARDS, DEAN P · 1994 to 2012
$3.1M
Metabolic Oxidative Stress in Human Cancer CellsR01CA100045 · NCI · UNIVERSITY OF IOWA · PI SPITZ, DOUGLAS ROBERT · 2004 to 2008
$1.8M
NCI NIH HHS P30 CA086862NCI NIH HHS P30-CA086862NCI NIH HHS R01 CA100045NCI NIH HHS R01CA100045NCRR NIH HHS P20 RR016477NCRR NIH HHS P20 RR020180NIDDK NIH HHS R01 DK049030NIDDK NIH HHS R01DK49030PHS HHS P01-66081
6 · The paper itself

Abstract

Superoxide dismutase (SOD) occurs in two intracellular forms in mammals, copper-zinc SOD (CuZnSOD), found in the cytoplasm, mitochondria and nucleus, and manganese superoxide dismutase (MnSOD), in mitochondria. Changes in MnSOD expression (as compared to normal cells) have been reported in several forms of cancer, and these changes have been associated with regulation of cell proliferation, cell death, and metastasis. We have found that progestins stimulate MnSOD in T47D human breast cancer cells in a time and physiological concentration-dependent manner, exhibiting specificity for progestins and inhibition by the antiprogestin RU486. Progestin stimulation occurs at the level of mRNA, protein, and enzyme activity. Cycloheximide inhibits stimulation at the mRNA level, suggesting that progestin induction of MnSOD mRNA depends on synthesis of protein. Experiments with the MEK inhibitor UO126 suggest involvement of the MAP kinase signal transduction pathway. Finally, MnSOD-directed siRNA lowers progestin-stimulated MnSOD and inhibits progestin stimulation of migration and invasion, suggesting that up-regulation of MnSOD may be involved in the mechanism of progestin stimulation of invasive properties. To our knowledge, this is the first characterization of progestin stimulation of MnSOD in human breast cancer cells.

Indexed as

Base SequenceBreast NeoplasmsButadienesCell Line, TumorDNA PrimersFemaleHormone AntagonistsHumansMAP Kinase Signaling SystemMifepristoneNeoplasm InvasivenessNitrilesProgesterone CongenersPromegestoneReceptors, ProgesteroneRNA, MessengerButadienesDNA PrimersHormone AntagonistsMifepristoneNitrilesProgesterone CongenersPromegestoneReceptors, ProgesteroneRNA, MessengerRNA, NeoplasmRNA, Small InterferingSuperoxide DismutaseU 0126

Identifiers

PMID19563893
PMCPMC2749892
OpenAlexW2073914544

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.